Michael Sofia
Chief Tech/Sci/R&D Officer en ARBUTUS BIOPHARMA CORPORATION .
Fortuna: 4 M $ al 31/03/2024
Origen de la red de primer grado Michael Sofia.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 39 | |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ.
29
| Subsidiary | Pharmaceuticals: Other | 29 |
| Public Company | Biotechnology | 17 | |
Baruch S. Blumberg Institute
4
| Non-Profit Organization | 4 | |
Bristol-Myers Squibb Pharma Research Labs LLC
 Bristol-Myers Squibb Pharma Research Labs LLC Miscellaneous Commercial ServicesCommercial Services Bristol-Myers Squibb Pharma Research Labs LLC researches and develops drugs and related pharmaceutical products. The company is headquartered in San Diego, CA
2
| Subsidiary | Miscellaneous Commercial Services | 2 |
Transcell Technology, Inc.
 Transcell Technology, Inc. Industrial MachineryProducer Manufacturing Transcell Technology, Inc. manufactures load cells, postal scales, precision balances, and industrial scales. It offers digital scale, load cells, process weighing, and scale parts and accessories. The company was founded in 1981 and is headquartered in Buffalo Grove, IL.
1
| Private Company | Industrial Machinery | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Michael Sofia a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| REGENERON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel Director of Finance/CFO | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
| PHARMACYCLICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Investor Relations Contact General Counsel | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| CHIMERIX, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| CHIASMA, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
OMRIX Biopharmaceuticals, Inc.
 OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| UNILIFE CORP | Medical Specialties | Director of Finance/CFO Compliance Officer | |
| EUPRAXIA PHARMACEUTICALS INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Arbutus Biopharma, Inc.
 Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Founder Director/Board Member Chief Executive Officer Chief Executive Officer | |
| ROIVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer President | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Undergraduate Degree Doctorate Degree | |
| MEDIGENE AG | Biotechnology | Director/Board Member Director/Board Member | |
| University of Oxford | College/University | Doctorate Degree Masters Business Admin | |
| Rice University | College/University | Undergraduate Degree Doctorate Degree | |
| University of British Columbia | College/University | Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
| University of California, Davis | College/University | Undergraduate Degree Doctorate Degree | |
| University of California, Santa Barbara | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Michigan | College/University | Corporate Officer/Principal Undergraduate Degree | |
| Hepatitis B Foundation | Director/Board Member Founder Chairman | ||
| KITE PHARMA INC | Biotechnology | Director of Finance/CFO Corporate Secretary Chief Tech/Sci/R&D Officer | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Pulmocide Ltd.
 Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Pulmocide Ltd. provides biopharmaceutical services. It develops inhaled medicines for viral and fungal infections of the respiratory tract. The company was founded by William Garth Rapeport, John Murray, Kazuhiro Ito, and Peter Strong on March 23, 2007 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| ASSEMBLY BIOSCIENCES, INC. | Pharmaceuticals: Major | Founder Director of Finance/CFO Director/Board Member | |
Roivant Sciences GmbH
 Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Operating Officer | |
| SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Chairman Chief Executive Officer Director/Board Member | |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Pharmaceuticals: Major | Director of Finance/CFO Chairman Chief Executive Officer | |
Myovant Sciences, Inc.
 Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Myovant Sciences, Inc. offers therapeutics for women's health and prostate cancer. The company is headquartered in New York, NY. | Medical Specialties | President Director/Board Member | |
| MYOVANT SCIENCES LTD. | Biotechnology | Director of Finance/CFO Chairman Director/Board Member Director/Board Member Chairman | |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal President | |
Genevant Sciences Corp.
 Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The private company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer Director/Board Member | |
| IMMUNOVANT, INC. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
Altavant Sciences, Inc.
 Altavant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Altavant Sciences, Inc. is a clinical stage biopharmaceutical company, which provides therapies that treat respiratory diseases with an initial therapeutic focus in pulmonary arterial hypertension (PAH). The company is headquartered in Cary, NC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
Dermavant Sciences, Inc.
 Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The private company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | Biotechnology | Director/Board Member Chairman | |
| NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
Aruvant Sciences, Inc.
 Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Aruvant Sciences, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning. It's lead candidate ARU-1801, is a modified fetal hemoglobin gene therapy for sickle cell disease and related hemoglobinopathies. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| UROVANT SCIENCES LTD. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Urovant Sciences, Inc.
 Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The private company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Sumitovant Biopharma, Inc.
 Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 36 |
| Canadá | 7 |
| Reino Unido | 7 |
| Alemania | 2 |
| Suiza | 2 |
Sectorial
| Health Technology | 40 |
| Consumer Services | 10 |
| Finance | 2 |
Operativa
| Director/Board Member | 391 |
| Corporate Officer/Principal | 191 |
| Independent Dir/Board Member | 102 |
| Chairman | 76 |
| Undergraduate Degree | 65 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Ansbert Gadicke | 56 |
| G. Steven Burrill | 44 |
| Myrtle Potter | 41 |
| Frank Torti | 35 |
| Robin Washington | 34 |
| Elizabeth Tallett | 28 |
| Daniel Burgess | 27 |
| Carol Brosgart | 25 |
| Herbert Conrad | 21 |
| Alan S. Roemer | 21 |
| Fredric D. Price | 16 |
| Michael Jeffrey Abrams | 16 |
| Keith Manchester | 15 |
| Adam Daniel Cutler | 15 |
| Brett Pletcher | 15 |
- Bolsa de valores
- Insiders
- Michael Sofia
- Conexiones Empresas
